Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PROTAC Linker
    (3)
  • ADC Linker
    (2)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
Filter
Search Result
Results for "

m-peg-2-amine

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • PROTAC Products
    3
    TargetMol | PROTAC
  • ADC/ADC Related
    2
    TargetMol | All_Pathways
  • m-PEG2-Amine
    T1584231576-51-9
    m-PEG2-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].
    • Inquiry Price
    7-10 days
    Size
    QTY
  • m-PEG-NH2 (MW 1000)
    mPEG-NH2 (MW 1000), mPEG-amine (MW 1000)
    T18097
    m-PEG-NH2 (MW 1000) is a PEG-based PROTAC linker. m-PEG-amine (MW 1000) can be used to synthesize PROTAC.
    • $30
    In Stock
    Size
    QTY
  • m-PEG12-amine
    T158391977493-48-3
    m-PEG12-amine is a PEG-based PROTAC linker and a non-cleavable 12-unit PEG ADC linker used in the synthesis of PROTACs [1] and antibody-drug conjugates (ADCs) [2].
    • $40
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • DSPE-PEG(2000)-amine (sodium salt)
    T36424
    DSPE-PEG(2000)-amine is a PEGylated derivative of 1,2-distearoyl-sn-glycero-3-PE . It has been used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents.1,2,3DSPE-PEG(2000)-amine has also been used in the synthesis of fluorescein isothiocyanate-loaded mesoporous silica nanoparticles for imaging applications.4It can be conjugated to a variety of functional molecules for improved cellular targeting and uptake of DSPE-PEG(2000)-amine-containing nanoparticles.4,5 1.Sloat, B.R., Sandoval, M.A., Li, D., et al.In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesInt. J. Pharm.409(1-2)278-288(2011) 2.Abd-Rabou, A.A., Bharali, D.J., and Mousa, S.A.Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancerPharm. Res.35(4)76(2018) 3.Affram, K., Udofot, O., Singh, M., et al.Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imagingPLoS One12(9):e0815116(2017) 4.Wang, L.-S., Wu, L.-C., Lu, S.-Y., et al.Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: Improved water suspensibility and decreased nonspecific protein bindingACS Nano4(8)4371-4379(2010) 5.Wen, X., Wang, K., Zhao, Z., et al.Brain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticlesPLoS One9(9):e106652(2014)
    • $323
    35 days
    Size
    QTY